(Adnkronos) – “We have already had more than 1,500 deaths since the beginning of the year. For prevention in immunocompromised patients we have monoclonal antibodies.” Massimo Andreoni, professor emeritus of Infectious Diseases at the Tor Vergata University of Rome, told Adnkronos Salute. on the sidelines of the final National Event which took place in the capital, “The management of COVID-19 prophylaxis as a paradigm of a new organizational model” of the Prevention Management LAboratory (PMLAb) project, conceived by Dephaforum with the support of AstraZeneca Italia, during which presented the guidelines relating to the ideal organizational model for COVID-19 PrEP and the care and management of the immunocompromised patient.
#Covid #Andreoni #Tor #Vergata #disease #endemic #phase #guard
Waiting list decree, Schillaci plan supported by 86% of Italians. Visits and exams also on weekends among the most appreciated measures
Approval for the decree law launched by the Minister of Health, Orazio Schillaci, to reduce waiting lists. This is revealed...